Coronavirus outbreak exposes a weak link in the U.S. drug supply - STAT

Coronavirus outbreak exposes a weak link in the U.S. drug supply - STAT

Opinion: The coronavirus outbreak exposes the U.S.’s pharma supply chain vulnerability

By MARSHA BLACKBURN

ADOBE

The U.S. has ceded the manufacturing of active pharmaceutical ingredients to China and India. The coronavirus outbreak shows why that was a mistake.

READ MORE